With a new $2.4 million R01 grant from the @Alzheimers_NIH UW–Madison School of Pharmacy professor Lingjun Li and collaborators, including those at @WisconsinADRC, are taking aim at Alzheimer's biomarkers for earlier discovery and treatment of the disease: https://t.co/l4eJWGAlRg